Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for military-related posttraumatic stress disorder.  For more information, please visit www.thehonorstudy.com or www.clinicaltrials.gov (NCT03062540).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
02/13/17 5 Annual statement of changes in beneficial ownership of securities 2
02/13/17 5 Annual statement of changes in beneficial ownership of securities 2
02/10/17 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 11
02/10/17 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 5
02/10/17 8-K Current report filing
Related Documents
47
01/31/17 8-K Current report filing
Related Documents
47
01/10/17 8-K Current report filing
Related Documents
45
01/03/17 8-K Current report filing
Related Documents
42
12/19/16 8-K Current report filing
Related Documents
42
12/08/16 8-K Current report filing
Related Documents
41